NanHua Bio-medicine Co., Ltd

000504.SZ

000504.SZNanHua Bio-medicine Co., Ltd

Shenzhen

7.29

CNY

-0.14

(-1.88%)

-0.09EPS

-81.00P/E

2.41BMarket Cap

May 23Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

NanHua Bio-medicine Co., Ltd

000504.SZ

(Shenzhen)

Recent

price

7.29

P/E

ratio

-81

div

yld

- -

ROIC.AI

Legends:

Stock price

Beta (1.0 Market)

% total return 09/15

Stock

S&P500

-34.32

26.76

-67.91

25.48

-19.54

87.24

2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	TTM
0.64	0.57	0.47	0.3	0.25	0.08	0.06	0.04	0.22	0.22	0.3	0.43	0.65	0.49	0.64	0.44	0.37	Revenue per Share
-0.55	-0.43	0.02	-0.1	-0.48	0.04	-0.08	-0.07	0.07	-0.12	-0.11	0.06	0.03	-0.06	-0.04	-0.09	-0.08	Basic EPS, GAAP
-0.07	0.19	-0.2	-0.01	-0.01	-0.1	-0.1	-0.1	-0.06	-0.16	-0.08	0.04	-0.78	0.24	0.48	0.1	-0.02	Free Cash Flow per Basic Share
0.03	0.02	- -	- -	- -	- -	- -	0.01	0.01	0.03	0.03	0.04	- -	0.01	0.01	0.01	0.02	Dividend per Share
0.66	0.22	0.24	0.16	-0.33	-0.26	-0.35	-0.45	-0.37	-0.49	-0.58	-0.54	-0.59	-0.56	-0.61	-0.64	-0.64	Book Value per Share
0.13	-0.11	-0.05	-0.16	-0.16	-0.05	-0.03	-0.1	0.15	0.32	0.12	0.32	0.45	0.32	0.23	0.97	0.88	Tangible Book Value per Share
309	313	323	299	311	345	327	303	311	309	320	313	272	319	311	313	330	Basic Weighted Avg Shares
197	178	152	91	77	26	18	13	67	67	95	134	176	157	200	137	123	Sales/Revenue/Turnover
-8.72	-13.02	0.84	-9.72	7.44	-73.08	-95.49	-135.53	-9.03	-39.9	-13.7	-3.82	13.92	2.55	6.09	-6.62	-11.91	Operating Margin (%)
4	4	3	1	1	1	5	5	4	2	5	6	3	7	6	6	- -	Depreciation Expense
-170	-135	6	-30	-149	14	-26	-21	22	-37	-35	19	8	-19	-12	-28	-28	Net Income, GAAP
- -	- -	3.96	- -	- -	39.49	- -	- -	11.96	- -	- -	- -	22.84	- -	- -	- -	6.61	Effective Tax Rate (%)
-86.13	-75.52	4.25	-32.9	-194.27	52.52	-142.34	-158.65	32.35	-55.08	-36.89	14.02	4.64	-12.21	-6.22	-20.6	-22.49	Profit Margin (%)
-42	-89	-42	-70	-51	-67	-62	-75	-40	-14	-80	-6	59	-12	-39	202	198	Working Capital
1	1	1	1	1	1	1	1	1	20	1	1	19	17	15	13	11	LT Debt
278	144	161	130	-21	4	7	-15	80	128	108	114	134	110	80	305	293	Total Equity
- -	- -	0.98	- -	- -	- -	- -	- -	-5.91	- -	- -	- -	11.02	- -	- -	- -	- -	Return on Invested Capital (%)
- -	- -	8	- -	- -	-16.37	- -	- -	259.44	- -	- -	- -	-24.94	- -	- -	- -	-79.9	Return on Capital (%)
-58.69	-98.01	8.82	-48.57	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Return on Common Equity (%)

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	44.42%	11.39%	-31.72%
Net Income, GAAP	-124%	-90.67%	126.15%
Free Cash Flow	-208.29%	-427.36%	-79.69%
Total Cash Common Dividend	- -	8.44%	-4.69%
Total Equity	-55.61%	51.68%	279.96%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Business: NanHua Bio-medicine Co., Ltd. provides stem and immune cell storage, noninvasive genetic testing, and biological research and technical services. The company is based in Changsha, China.

	Dec'23	Mar'24	Jun'24
ST Debt	31	28	3
LT Borrowings	- -	- -	- -
LT Finance Leases	13	14	11
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	330	330	330
Market Capitalization	3,638	2,853	2,276

2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	TTM
0.64	0.57	0.47	0.3	0.25	0.08	0.06	0.04	0.22	0.22	0.3	0.43	0.65	0.49	0.64	0.44	0.37	Revenue per Share
-0.55	-0.43	0.02	-0.1	-0.48	0.04	-0.08	-0.07	0.07	-0.12	-0.11	0.06	0.03	-0.06	-0.04	-0.09	-0.08	Basic EPS, GAAP
-0.07	0.19	-0.2	-0.01	-0.01	-0.1	-0.1	-0.1	-0.06	-0.16	-0.08	0.04	-0.78	0.24	0.48	0.1	-0.02	Free Cash Flow per Basic Share
0.03	0.02	- -	- -	- -	- -	- -	0.01	0.01	0.03	0.03	0.04	- -	0.01	0.01	0.01	0.02	Dividend per Share
0.66	0.22	0.24	0.16	-0.33	-0.26	-0.35	-0.45	-0.37	-0.49	-0.58	-0.54	-0.59	-0.56	-0.61	-0.64	-0.64	Book Value per Share
0.13	-0.11	-0.05	-0.16	-0.16	-0.05	-0.03	-0.1	0.15	0.32	0.12	0.32	0.45	0.32	0.23	0.97	0.88	Tangible Book Value per Share
309	313	323	299	311	345	327	303	311	309	320	313	272	319	311	313	330	Basic Weighted Avg Shares
197	178	152	91	77	26	18	13	67	67	95	134	176	157	200	137	123	Sales/Revenue/Turnover
-8.72	-13.02	0.84	-9.72	7.44	-73.08	-95.49	-135.53	-9.03	-39.9	-13.7	-3.82	13.92	2.55	6.09	-6.62	-11.91	Operating Margin (%)
4	4	3	1	1	1	5	5	4	2	5	6	3	7	6	6	- -	Depreciation Expense
-170	-135	6	-30	-149	14	-26	-21	22	-37	-35	19	8	-19	-12	-28	-28	Net Income, GAAP
- -	- -	3.96	- -	- -	39.49	- -	- -	11.96	- -	- -	- -	22.84	- -	- -	- -	6.61	Effective Tax Rate (%)
-86.13	-75.52	4.25	-32.9	-194.27	52.52	-142.34	-158.65	32.35	-55.08	-36.89	14.02	4.64	-12.21	-6.22	-20.6	-22.49	Profit Margin (%)
-42	-89	-42	-70	-51	-67	-62	-75	-40	-14	-80	-6	59	-12	-39	202	198	Working Capital
1	1	1	1	1	1	1	1	1	20	1	1	19	17	15	13	11	LT Debt
278	144	161	130	-21	4	7	-15	80	128	108	114	134	110	80	305	293	Total Equity
- -	- -	0.98	- -	- -	- -	- -	- -	-5.91	- -	- -	- -	11.02	- -	- -	- -	- -	Return on Invested Capital (%)
- -	- -	8	- -	- -	-16.37	- -	- -	259.44	- -	- -	- -	-24.94	- -	- -	- -	-79.9	Return on Capital (%)
-58.69	-98.01	8.82	-48.57	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Return on Common Equity (%)

NanHua Bio-medicine Co., Ltd

Growth Rates

(avg. rate of change)

Growth Rates

(avg. rate of change)

Capital Structure

Working Capital

Quarterly Dividends Per Share

Year

Quarterly Revenue

Year

Quarterly Earnings Per Share

Year

	Dec'23	Mar'24	Jun'24
Total Current Assets	655	498	472
Accounts Receivable, Net	123	124	125
Cash, Cash Equivalents & STI	496	313	307
Inventories	11	14	18
Total Current Liabilities	452	294	275
Payables & Accruals	- -	- -	- -
ST Debt	31	28	3
Deferred Revenue	- -	- -	- -